In a 6½‑year‑old thin girl with a family history of thinness who has fine pubic (vellus) hair, could this represent early adrenarche, or is it a normal finding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Velusne dlake u intimnom dijelu kod djevojčice od 6,5 godina – najvjerovatnije normalna varijanta razvoja

Kod ove djevojčice sa izraženom porodičnom maljavošću, velusne (fine, meke, nepigmentirane) dlake u pubičnom području u dobi od 6,5 godina najvjerovatnije predstavljaju normalnu varijaciju, a ne pravu adrenarhu ili patologiju. Ključna razlika je u tipu dlake – velusne dlake nisu terminalne dlake koje karakterišu pravu pubarhu 1, 2.

Razumijevanje adrenarhe i pubarhe

Adrenarha je fiziološki proces sazrijevanja zona reticularis nadbubrežne žlijezde koji normalno počinje između 6-8 godina 2, 3. Međutim, prvi klinički znak adrenarhe je razvoj terminalnih (debljih, pigmentiranih) dlaka, a ne velusnih 4, 2.

Ključne razlike:

  • Velusne dlake: fine, meke, nepigmentirane – mogu biti prisutne kod djece bez hormonalne aktivnosti
  • Terminalne dlake: deblje, pigmentirane, grube – pravi znak adrenalne ili gonadne androgene aktivnosti

Genetska maljavost vs. hormonalna aktivnost

Vaša opservacija o porodičnoj maljavosti je veoma relevantna. Smjernice jasno navode da količina, distribucija i progresija tjelesnih dlaka imaju rasne, porodične i genetske uticaje 1. Kod djece sa genetskom predispozicijom za maljavost:

  • Velusne dlake mogu biti brojnije i vidljivije
  • Ovo je prepubertalna prosta hipertrichoza, a ne hirsutizam 1
  • Hormonalni nivoi su normalni 1

Kada posumnjati na patologiju

Prema najnovijim smjernicama 5, 6, testiranje je indikovano samo ako postoje dodatni znaci androgenog viška kod prepubertalnog djeteta:

  • Brzi rast i ubrzana koštana dob
  • Rani tjelesni miris odraslih
  • Aksilarno dlakanje (terminalno)
  • Genitalno sazrijevanje ili klitoromegalija
  • Akne otporne na terapiju
  • Brza progresija dlakanja

Bez ovih "crvenih zastavica", rutinsko laboratorijsko testiranje nije opravdano 7, 6. Nedavna studija iz 2025. godine pokazuje da je adrenalna patologija kod djece upućene zbog preuranjene pubarhe izuzetno rijetka (0,52%) 7.

Praktični pristup

Što odmah procijeniti:

  1. Tip dlake: Jesu li dlake zaista velusne (fine, meke) ili terminalne (deblje, pigmentirane)?
  2. Tempo rasta: Praćenje visine i brzine rasta na percentilnim krivuljama
  3. Drugi znaci: Tjelesni miris, aksilarno dlakanje, promjene genitalija
  4. Progresija: Koliko brzo se dlakanje razvija

Ako su dlake velusne i nema drugih znakova:

  • Nema potrebe za laboratorijskim testiranjem 6
  • Uvjeravanje roditelja da je ovo normalna varijacija
  • Praćenje rasta i razvoja na redovnim kontrolama
  • Ponovni pregled samo ako se pojave novi znaci

Ako postoje sumnje ili dodatni znaci:

  • Procjena koštane dobi (RTG šake)
  • DHEAS, testosteron
  • Upućivanje dječjem endokrinologu

Važna napomena o prematurnoj adrenarhi

Čak i kada postoji prava prematurna adrenarha (prije 8 godina kod djevojčica), većina slučajeva je benigna varijacija razvoja 2, 8, 6. Djeca sa prematurnom adrenarhom tipično imaju:

  • Umjereno ubrzani rast koji obično ne kompromituje konačnu visinu 2
  • Blago povišene vrijednosti DHEAS i testosterona 2
  • Veću povezanost sa višim BMI 3, 9

Zaključna preporuka

Kod ove djevojčice sa porodičnom maljavošću i velusnim dlakama, bez drugih znakova androgenog viška, najvjerovatnije se radi o normalnoj genetskoj varijaciji. Preporučuje se:

  • Klinički nadzor bez laboratorijskih testova
  • Praćenje rasta na percentilnim krivuljama
  • Edukacija roditelja o znacima koji bi zahtijevali daljnju evaluaciju
  • Ponovni pregled ako dođe do brze progresije ili pojave novih znakova

Vaša intuicija da genetska maljavost čini sve vidljivijim je tačna i podržana medicinskom literaturom 1.

References

1
Guideline

american association of clinical endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2001

2
Research

Normal and Premature Adrenarche.

Endocrine reviews, 2021

3
Research

Update on adrenarche.

Current opinion in pediatrics, 2020

5
Guideline

guidelines of care for the management of acne vulgaris.

Journal of the American Academy of Dermatology, 2016

6
Research

Premature Pubarche: A Pragmatic Approach.

Endocrinology and metabolism clinics of North America, 2024

8
Research

Present Knowledge on the Etiology and Treatment of Adrenarche.

Pediatric endocrinology reviews : PER, 2018

9
Research

Approach to the girl with early onset of pubic hair.

The Journal of clinical endocrinology and metabolism, 2011

Related Questions

In a 6½‑year‑old child with only fine vellus hair in the genital area (Tanner stage P1‑P2), slightly oily scalp hair, and a few tiny facial comedones, could this represent a mild form of premature adrenarche?
What is premature adrenarche?
In a child who is 131.5 cm tall (above average for age) and comes from a family of very tall individuals, how should early pubic hair development be evaluated—should we consider premature adrenarche versus congenital adrenal hyperplasia, and what endocrine tests and imaging are indicated?
In a 6‑year‑4‑month‑old girl with a strong familial pattern of hirsutism, can early isolated pubic hair (Tanner stage P1) be a normal variant, and what endocrine evaluation and monitoring are recommended?
In a 6½‑year‑old girl with fine pubic hair (Tanner stage P1), oily scalp, bone age advanced by 15 months, no breast development or other symptoms, and a family history of extreme tall stature, what is the recommended evaluation and management?
What is the recommended tapering schedule for bupropion (Wellbutrin) and how should I initiate vortioxetine (Trintellix) in a 72-year-old patient who drinks alcohol daily?
In a 22‑year‑old woman with a history of migraine with aura since age 12 who presents with a prolonged morning headache refractory to rizatriptan, acetaminophen, and ibuprofen, and reports posterior neck tension, what differential diagnoses should be considered?
How long can fatigue persist after discontinuing Latuda (lurasidone) 12 days ago?
In an 85-year-old woman with chronic heart failure, COPD, shortness of breath, severe chronic kidney disease (eGFR 16–28 mL/min), hyperkalemia (potassium 5.1–5.5 mmol/L), anemia with low transferrin saturation, secondary hyperparathyroidism, and markedly elevated NT‑proBNP, how should her volume status and guideline‑directed heart‑failure therapy be optimized?
What are the recommended fluvoxamine dosage guidelines for adults with obsessive‑compulsive disorder, children and adolescents, and patients with liver disease or the elderly?
In a 40‑year‑old woman with blunt abdominal trauma who was initially hypotensive but is now hemodynamically stable (blood pressure 100/80 mm Hg) and CT shows contrast extravasation near the left kidney with a perirenal hematoma, what is the most appropriate management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.